Severe Course of Crohn's Disease Complicated with Multiple Peristomal Fistulas

• Authors: Zbigniew Banaszkiewicz , Maria Kłopocka , Arkadiusz Jawień
• Languages of publication: EN

Abstracts

EN

To date healthy male, 51, was admitted to hospital for abdominal pain and body weight loss of 10 kilograms within 6 weeks. Soon after admittance the patient's condition deteriorated and he was operated on for ileus. The Hartman's resection of sigmoid colon was the option for obstructive tumour. First signs of stoma complications were being reported from day 16 on and soon overt multiple fistula formation was diagnosed. Systemic and site treatment was involved (5-ASA, steroids). Nevertheless, the patient's condition was not improving within following 8 months, which led to succeeding hospitalisations, finally, infliximab therapy was the successful one. On patient's demand the hind-gut reconstruction was performed. Partial resection of involved bowel and stoma followed by end-to-end hind-gut reconstruction was the option. Up to now (i.e. 8 months after the reconstruction) the patient remains in good condition.

Keywords

EN

Crohn's disease; peristomal fistula; stoma

• Publisher: Index Copernicus International
• Journal: Polish Journal of Surgery
• Year: 2009
• Volume: 81
• Issue: 4
• Pages: 198-202

Dates

published

1 - 4 - 2009

online

14 - 5 - 2009

Contributors

author

Zbigniew Banaszkiewicz

• Department of General and Vascular Surgery, Sub-Department of Gastroenterological and Colorectal Surgery, 2 Dr J. Biziel Memorial University Hospital, Bydgoszcz

author

Maria Kłopocka

• Department of Gastroenterology, 2 Dr J. Biziel Memorial University Hospital, Bydgoszcz

author

Arkadiusz Jawień

• Department of General and Vascular Surgery, Sub-Department of Gastroenterological and Colorectal Surgery, 2 Dr J. Biziel Memorial University Hospital, Bydgoszcz

References

• Silverberg MS, Satsangi J, Ahmad T, et al.: Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19(Suppl A): 5A-36A.[PubMed]
• Knutson D, Greenberg G, Cronau H: Management of Crohn's Disease - A practical approach. Am Fam Physician 2003; 68: 707-14.[PubMed]
• Podolsky DK: Inflammatory bowel disease. NEJM 2002; 347: 417-29.
• Gasche C, Scholinerich J, Brynskov J, et al: A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflammatory Bowel Diseases 2000; 6: 8-15.
• Poritz LS, Gagliano GA, McLeod RS, et al.: Surgical management of entero and colocutaneous fistulae in Crohn's disease: 17 year's experience Int J Colorectal Dis 2004; 19(5): 481-85.
• Banaszkiewicz Z, Jarmocik P, Tojek K i wsp.: Retrospektywna ocena wybranych czynników odpowiadających za powstanie późnych, miejscowych powikłań kolostomii Chir Polska 2003; 5(4): 221-27.
• Bartnik W: Postępy w leczeniu nieswoistych zapaleń jelit. Terapia 2006; 6: 13-17.
• Dejaco C, Harrer M, Waldhoer T, et al.: Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment Pharmacol Ther 2003; 18: 1113-20.[PubMed][Crossref]
• Felley C, Mottet C, Juillerat P, et al.: Fistulizing Crohn's disease. Digestion 2005; 71: 26-28.[Crossref][PubMed]
• Sandborn WJ: New concepts in anti-tumor necrosis factor therapy for inflammatory bowel disease. Rev Gastroenterol Disord 2005; 5: 10-18.[PubMed]
• Sands BE: Therapy of inflammatory bowel disease. Gastroenterology 2000; 118: S68-S82.[PubMed][Crossref]
• Colombel JF, Loftus EV Jr., Tremaine WJ, et al.: Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004; 99: 878-83.[PubMed][Crossref]
• Marchal L, D'Haens G, Van Assche G, et al.: The risk of post-operative compli cations associated with infliximab therapy for Crohn's disease: a controlled cohort study. Aliment Pharmacol Ther 2004; 19: 740-54.
• Deshpande AR, Abreu MT: Combination Therapy With Infliximab and Immunomodulators: Is the Glass Half Empty. Gastroenterology 2008;134: 2161-63.
• Van Assche G, Magdaleine-Beuzelin CD, Haens G, et al.: Withdrawal of Immunosuppresion in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial. Gastroenterology 2008; 134: 1861-68.

Identifiers

DOI

10.2478/v10035-009-0030-0